Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incidence, prevalence and clinical correlates of antidepressant‐emergent mania in bipolar depression: a systematic review and meta‐analysis
Michele Fornaro, Annalisa Anastasia, Stefano Novello, et al.
Bipolar Disorders (2018) Vol. 20, Iss. 3, pp. 195-227
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Bipolar disorders
Roger S. McIntyre, Michael Berk, Elisa Brietzke, et al.
The Lancet (2020) Vol. 396, Iss. 10265, pp. 1841-1856
Closed Access | Times Cited: 668
Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies
Roger S. McIntyre, Trisha Suppes, Willie Earley, et al.
CNS Spectrums (2019) Vol. 25, Iss. 4, pp. 502-510
Open Access | Times Cited: 190
Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis
Ayşegül Yıldız, Spyridon Siafis, Dimitris Mavridis, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 9, pp. 693-705
Open Access | Times Cited: 41
Synthesising 30 years of clinical experience and scientific insight on affective temperaments in psychiatric disorders: State of the art
Ettore Favaretto, Fulvio Bedani, Giulio Emilio Brancati, et al.
Journal of Affective Disorders (2024) Vol. 362, pp. 406-415
Closed Access | Times Cited: 31
Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis
Anees Bahji, Dylan Ermacora, Callum Stephenson, et al.
Journal of Affective Disorders (2020) Vol. 269, pp. 154-184
Closed Access | Times Cited: 114
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials
Anastasiya Nestsiarovich, Christopher Gaudiot, Ross J. Baldessarini, et al.
European Neuropsychopharmacology (2021) Vol. 54, pp. 75-89
Open Access | Times Cited: 56
The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?
Michele Fornaro, Annalisa Anastasia, Alessandro Valchera, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 72
Modelling mood disorders: An ACE solution?
Gin S. Malhi, Lauren Irwin, Amber Hamilton, et al.
Bipolar Disorders (2018) Vol. 20, Iss. S2, pp. 4-16
Open Access | Times Cited: 68
The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials
Michele Fornaro, André F. Carvalho, Andrea Fusco, et al.
Journal of Affective Disorders (2020) Vol. 276, pp. 970-983
Closed Access | Times Cited: 54
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis
Michele Fornaro, André F. Carvalho, Michele De Prisco, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 289-303
Closed Access | Times Cited: 41
Is it depression or is it bipolar depression?
Donna Rolin, Jessica Whelan, C. Brendan Montano
Journal of the American Association of Nurse Practitioners (2020) Vol. 32, Iss. 10, pp. 703-713
Open Access | Times Cited: 46
The prevalence, odds and predictors of lifespan comorbid eating disorder among people with a primary diagnosis of bipolar disorders, and vice-versa: Systematic review and meta-analysis
Michele Fornaro, Federico M. Daray, Fernando Hunter, et al.
Journal of Affective Disorders (2020) Vol. 280, pp. 409-431
Closed Access | Times Cited: 41
A systematic review of manic/hypomanic and depressive switches in patients with bipolar disorder in naturalistic settings: The role of antidepressant and antipsychotic drugs
Margherita Barbuti, Giulia Menculini, Norma Verdolini, et al.
European Neuropsychopharmacology (2023) Vol. 73, pp. 1-15
Closed Access | Times Cited: 13
Antidepressants and Bipolar Disorder: The Plot Thickens
Natalie Gottlieb, Allan H. Young
American Journal of Psychiatry (2024) Vol. 181, Iss. 7, pp. 575-577
Closed Access | Times Cited: 5
Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years
Anders Jørgensen, Mathilde Marie Brünnich Sloth, Emma Neble Larsen, et al.
European Neuropsychopharmacology (2025) Vol. 93, pp. 51-57
Open Access
Cannabidiol as a Treatment for Mood Disorders: A Systematic Review: Le cannabidiol comme traitement des troubles de l’humeur: une revue systématique
Jairo Vinícius Pinto, Gayatri Saraf, Christian Frysch, et al.
The Canadian Journal of Psychiatry (2019) Vol. 65, Iss. 4, pp. 213-227
Open Access | Times Cited: 31
Comparison of serum microbiome composition in bipolar and major depressive disorders
Sang Jin Rhee, Hye-Young Kim, Yunna Lee, et al.
Journal of Psychiatric Research (2020) Vol. 123, pp. 31-38
Closed Access | Times Cited: 31
Comorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review
Anastasiya Slyepchenko, Luciano Minuzzi, Benício N. Frey
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 25
Efficacy of cariprazine in patients with bipolar depression and higher or lower levels of baseline anxiety: a pooled post hoc analysis
Rakesh K. Jain, Roger S. McIntyre, Andrew J. Cutler, et al.
International Clinical Psychopharmacology (2023) Vol. 39, Iss. 2, pp. 82-92
Open Access | Times Cited: 9
Druggable genome-wide Mendelian randomization for identifying the role of integrated stress response in therapeutic targets of bipolar disorder
Ting Zhai
Journal of Affective Disorders (2024) Vol. 362, pp. 843-852
Closed Access | Times Cited: 3
The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder
Roger S. McIntyre, Mehul Patel, Prakash S. Masand, et al.
Current Medical Research and Opinion (2020) Vol. 37, Iss. 1, pp. 135-144
Open Access | Times Cited: 24
Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings
Giordano D’Urso, Elena Toscano, Annarita Barone, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 121, pp. 110672-110672
Closed Access | Times Cited: 15
A pooled post hoc analysis evaluating the safety and tolerability of cariprazine in bipolar depression
Willie Earley, Maria Victoria Burgess, Ludmyla Rekeda, et al.
Journal of Affective Disorders (2019) Vol. 263, pp. 386-395
Open Access | Times Cited: 25
Antidepressant-Associated Mania in Bipolar Disorder: A Review and Meta-analysis of Potential Clinical and Genetic Risk Factors
Lindsay Melhuish Beaupre, Arun K. Tiwari, Vanessa F. Gonçalves, et al.
Journal of Clinical Psychopharmacology (2020) Vol. 40, Iss. 2, pp. 180-185
Closed Access | Times Cited: 23
Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis
Anees Bahji, Dylan Ermacora, Callum Stephenson, et al.
The Canadian Journal of Psychiatry (2020) Vol. 66, Iss. 3, pp. 274-288
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top